Adar Poonawalla is the visionary CEO of the Serum Institute of India, the world’s largest vaccine manufacturer. Under his leadership, the company gained global prominence for its pivotal role in mass-producing life-saving vaccines, including Covishield. Beyond healthcare, Poonawalla has aggressively diversified his portfolio into finance, luxury real estate, and sports.
Who is Adar Poonawalla? Religion, Caste, Net Worth, Family, IPL Team, and Source of Income

In May 2026, he significantly expanded his footprint in the sporting world by acquiring an 18% stake in the Adar Poonawalla IPL team, Rajasthan Royals. Partnering with the Laxmi Mittal and family in a deal valued at approximately $1.65 billion, Poonawalla now serves on the franchise board, marking a strategic move into the high-growth business of professional cricket.
Adar Poonawalla Biography
Adar Poonawalla, an alumnus of the University of Westminster, transformed the Serum Institute of India into a global powerhouse after becoming CEO in 2011. Renowned as a leading philanthropist, he has received numerous accolades, including being named to the Time 100 list of the world's most influential people.
Recently, he significantly diversified his business interests, notably acquiring a minority stake in Rajasthan Royals for approximately $1.65 billion alongside the Mittal family. For those researching his journey, the Adar Poonawalla wiki highlights his rapid expansion from healthcare into entertainment and sports as a hallmark of his 2026 investment strategy.
| Name | Adar Poonawalla |
|---|---|
| Date of Birth | January 14, 1981 |
| Age | 45 years old |
| Nationality | Indian |
| Birth Place | Pune, Maharashtra |
| Role | CEO of Serum Institute of India, Chairman of Poonawalla Fincorp |
| Net Worth | $24.2 billion (2026 estimate) |
| Relationship Status | Married to Natasha Poonawalla |
Adar Poonawalla Religion and Caste
The CEO of the Serum Institute of India, Adar Poonawalla, comes from the renowned Parsi community of India and follows Zoroastrianism. Many people searching for Adar Poonawalla religion are interested in learning about his Parsi heritage and family background.
Similarly, queries related to Adar Poonawalla caste often refer to his association with the Parsi community, which is considered an ethnic-religious group rather than a traditional caste within the Indian caste system.
Adar Poonawalla Age
Born on January 14, 1981, in Pune, Adar Poonawalla age is 45 years as of 2026. Since taking the helm as CEO of the Serum Institute of India in 2011, he has transformed the family business into a global powerhouse, providing affordable life-saving vaccines to over 140 countries. His leadership during the COVID-19 pandemic further solidified his reputation as a visionary, earning him a spot on Time magazine's list of the 100 most influential people in the world.
Adar Poonawalla Education
The 45-year-old CEO, Adar Poonawalla education began with his academic journey at The Bishop's School before moving to the UK to attend St Edmund's School, Canterbury. He later earned a bachelor's degree in management from the University of Westminster in London, providing him with the global perspective necessary to lead a multinational biotech giant.
Advertisement
Adar Poonawalla Family
Talking about the Adar Poonawalla family, they represent one of India's most influential industrial dynasties, maintaining a legacy that blends massive pharmaceutical success with a deep-rooted passion for thoroughbred horse racing. Beyond their corporate achievements, the family is renowned for their extensive collection of luxury automobiles and their significant contributions to urban development and sanitation projects in Pune.
Adar Poonawalla Father
Adar Poonawalla father is Dr. Cyrus Poonawalla, a billionaire businessman and the visionary founder of the Serum Institute of India. Established in 1966, he transformed the company into the world's largest vaccine manufacturer by volume, earning him global recognition as a titan of the healthcare industry.
Adar Poonawalla Mother
The late Villoo Poonawalla was the Adar Poonawalla mother, remembered as a prominent philanthropist and a pillar of the family. She was known for her active involvement in charitable initiatives and horse racing circles before her passing in 2010, which later inspired the naming of several foundation projects in her honour.
Adar Poonawalla Sister & Brothers
Regarding the Adar Poonawalla Sister & Brothers, Adar is the only child of Dr. Cyrus and Villoo Poonawalla. While he does not have any siblings to share his business responsibilities, he manages the vast Poonawalla Group of companies as the sole heir and Chief Executive Officer.
Adar Poonawalla Wife
Natasha Poonawalla is the Adar Poonawalla wife. She serves as the Chairperson of the Villoo Poonawalla Foundation and a Director at the Serum Institute. She is a well-known socialite and fashion icon who frequently bridges the worlds of global business and high-end philanthropy through her leadership roles.
Adar Poonawalla Net Worth & Salary
While official filings for Adar Poonawalla net worth & salary are not always public, his family’s wealth was estimated at approximately $24.2 billion in 2024, with recent reports placing his personal net worth around $16.3 billion. As the CEO of the world’s largest vaccine manufacturer, his income is derived from his leadership at the Serum Institute and his roles in various group companies.
Adar Poonawalla Business Ventures
The Adar Poonawalla business ventures have expanded significantly beyond pharmaceuticals, recently making headlines for acquiring an 18% stake in one of the best teams in IPL, Rajasthan Royals franchise, in May 2026. His portfolio is highly diversified, including a 50% stake in Karan Johar’s Dharma Productions, the chairmanship of Poonawalla Fincorp, and significant interests in clean energy, hospitality, and luxury real estate.
Frequently Asked Questions
Who is Adar Poonawala?
+
Who is Adar Poonawala?
Adar Poonawalla is a prominent Indian businessman and the CEO of the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume.
Conversation
(0 Comments)
Editor's Pick
Editor's Pick






-1778329532233.webp)









